Millions of Brits will soon get Omicron-busting Covid booster jabs within weeks

NEW Omicron-busting Covid boosters for Brits are available starting in September.

The UK’s health chiefs are the first to approve a new version of the Moderna jab, which targets two variants.

As UK health chiefs become the first in the world to approve an updated version of the Moderna jab, Brits will get a booster from September

1

Brits will be able to get a boost starting in September as UK health chiefs approve the Moderna jab.

Scientists believe the new vaccine will provide stronger protection as it produces antibodies that are closer to the current strain.

The rollout will begin in two weeks and will be offered to all over-50s, vulnerable people, and health and care workers — a total of 26million people.

Omicron-specific jabs will be given out as standard, with regulators also reviewing a new version of the Pfizer vaccine, while the originals are ­available as a back-up.

Steve Barclay, Health Secretary, said: “Vaccines remain our best defence against Covid and this safe and effective vaccine will broaden immunity and potentially improve protection against variants as we learn to live with this virus.”

China sounds alarm after detecting NEW virus ‘spread from shrews’ as 35 infected
Warning to anyone with key Covid symptom over risk of ‘long-term brain decline’

Dr Mary Ramsay of the UK Health Security Agency added: “By taking up the booster vaccine this autumn, you will increase your protection.”

Moderna’s updated jab targets both the original strain and the first version of Omicron — known as BA.1 — which took over in the UK last Christmas.

While it may not be exact as the current BA.4 Omicron and BA.5 Omicron versions, it is close enough to allow for a comparison. “significantly higher”Moderna said that immunity is a natural response.

The antibody booster is expected to reduce the risk of death and hospitalisation, as well provide greater protection against transmission.

After clinical trials had shown it to be effective, the MHRA approved its approval “triggers a strong immune response”Side effects are minimal compared to the original jab.

It is expected to decide on Pfizer’s new Omicron booster within weeks.

Stéphane Bancel, CEO of Moderna, said: “We are delighted with the MHRA’s authorisation of our next- ­generation Covid-19 vaccine.

Latest News

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here